Genetic Technologies (NASDAQ:GENE) Stock Passes Above Two Hundred Day Moving Average of $2.72

Genetic Technologies Limited (NASDAQ:GENE) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.72 and traded as high as $3.59. Genetic Technologies shares last traded at $3.36, with a volume of 41,823 shares trading hands.

Genetic Technologies Stock Up 5.0 %

The company has a current ratio of 1.67, a quick ratio of 1.55 and a debt-to-equity ratio of 0.02. The business has a 50-day moving average of $2.44 and a 200-day moving average of $2.72.

Institutional Trading of Genetic Technologies

A hedge fund recently raised its stake in Genetic Technologies stock. Scarborough Advisors LLC boosted its position in shares of Genetic Technologies Limited (NASDAQ:GENE) by 5,054.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 548,372 shares of the biotechnology company’s stock after purchasing an additional 537,734 shares during the period. Scarborough Advisors LLC owned 2.85% of Genetic Technologies worth $417,000 at the end of the most recent reporting period. 0.63% of the stock is owned by hedge funds and other institutional investors.

About Genetic Technologies

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate.